GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Novo Nordisk A/s (NVO) [hlAlert]

Rating:
Buy NVO
up 16.44 %

Novo Nordisk A/s (NVO) upgraded to Buy by BofA/Merrill

Posted on: Tuesday,  Feb 25, 2014  9:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Novo Nordisk A/s (NYSE: NVO) on 02/25/2014, when the stock price was $48.23. Since
then, Novo Nordisk A/s has gained 16.44% as of 01/08/2016's recent price of $56.16.
If you would have followed this BofA/Merrill's recommendation on NVO, you would have gained 16.44% of your investment in 682 days.

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2014 9:25 AM Buy
None
48.23
as of 10/17/2014
1 Week up  1.60 %
1 Month down  -8.56 %
3 Months down  -2.95 %
1 YTD down  -8.10 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/17/2013 8:25 AM Hold
None
32.64

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy